Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Thill

Showing results (1-10 of 165) with videos related to

Pageof 17
Sort By:
Breast Care (Basel, Switzerland)|April 26, 2019
Biosimilar Trastuzumab in Clinical Trials: Differences or Not?Marc Thill
Expert Review of Medical Devices|May 15, 2013
MarginProbe: intraoperative margin assessment during breast conserving surgery by using radiofrequency spectroscopyMarc Thill
Expert Review of Anticancer Therapy|December 26, 2014
New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancerMarc Thill
Breast Care (Basel, Switzerland)|February 26, 2019
Benign Breast DiseasesMarc Thill
Breast Care (Basel, Switzerland)|March 21, 2014
New technologies in breast cancer surgeryMarc Thill, Kristin Baumann
Breast Care (Basel, Switzerland)|August 6, 2016
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016Cornelia Liedtke, Marc Thill,
Breast Care (Basel, Switzerland)|August 6, 2016
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2016Marc Thill, Cornelia Liedtke,
Therapeutic Advances in Medical Oncology|September 12, 2018
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancerMarc Thill, Marcus Schmidt
Journal of Surgical Oncology|May 28, 2014
Intraoperative assessment of margins in breast conservative surgery--still in use?Marc Thill, Kristin Baumann, Jana Barinoff
Oncology Research and Treatment|May 14, 2016
Targeted Therapy in HER2-Positive Breast CancerMarc Thill, Clayton Kraft, Michael Friedrich
Pageof 17

Showing results (1-10 of 165) with videos related to

Sort By:
Pageof 17
Breast Care (Basel, Switzerland)|April 26, 2019
Biosimilar Trastuzumab in Clinical Trials: Differences or Not?Marc Thill
Expert Review of Medical Devices|May 15, 2013
MarginProbe: intraoperative margin assessment during breast conserving surgery by using radiofrequency spectroscopyMarc Thill
Expert Review of Anticancer Therapy|December 26, 2014
New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancerMarc Thill
Breast Care (Basel, Switzerland)|February 26, 2019
Benign Breast DiseasesMarc Thill
Breast Care (Basel, Switzerland)|March 21, 2014
New technologies in breast cancer surgeryMarc Thill, Kristin Baumann
Breast Care (Basel, Switzerland)|August 6, 2016
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2016Cornelia Liedtke, Marc Thill,
Breast Care (Basel, Switzerland)|August 6, 2016
AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2016Marc Thill, Cornelia Liedtke,
Therapeutic Advances in Medical Oncology|September 12, 2018
Management of adverse events during cyclin-dependent kinase 4/6 (CDK4/6) inhibitor-based treatment in breast cancerMarc Thill, Marcus Schmidt
Journal of Surgical Oncology|May 28, 2014
Intraoperative assessment of margins in breast conservative surgery--still in use?Marc Thill, Kristin Baumann, Jana Barinoff
Oncology Research and Treatment|May 14, 2016
Targeted Therapy in HER2-Positive Breast CancerMarc Thill, Clayton Kraft, Michael Friedrich
Pageof 17